DCBLD2抗体,Rabbit Polyclonal DCBLD2 Antibody
  • DCBLD2抗体,Rabbit Polyclonal DCBLD2 Antibody
  • DCBLD2抗体,Rabbit Polyclonal DCBLD2 Antibody
  • DCBLD2抗体,Rabbit Polyclonal DCBLD2 Antibody

DCBLD2抗体

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 湖北
更新日期 2025-05-11
QQ交谈 微信洽谈

产品详情

中文名称:DCBLD2抗体英文名称:Rabbit Polyclonal DCBLD2 Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 1909 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: DCBLD2
2025-05-11 DCBLD2抗体 Rabbit Polyclonal DCBLD2 Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 1909 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC1/100-1/300 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa1/2000-1/10000 Human,Mouse,Rat
   

产品详情

AliasesFIH1; PTH1
Entrez GeneID5741
clone8C5H9
WB Predicted band size12.8kDa
Host/IsotypeMouse IgG2b
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenPurified recombinant fragment of human PTH (AA: 32-115) expressed in E. Coli.
FormulationPurified antibody in PBS with 0.05% sodium azide

+ +

  •  

     

       Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)    


  •  

     

       Immunofluorescence analysis of Hela cells using PTH mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)    


  •  

     

       Flow cytometric analysis of Hela cells using PTH mouse mAb (green) and negative control (red).    


  •  

     

       Flow cytometric analysis of HepG2 cells using PTH mouse mAb (green) and negative control (red).    


  •  

     

       Immunohistochemical analysis of paraffin-embedded human stomach cancer tissues using PTH mouse mAb with DAB staining.    


           

参考文献

以下是关于DCBLD2抗体的示例参考文献(注:部分文献信息为示例性概括,建议通过PubMed等数据库核实完整内容):

1. **"DCBLD2 modulates vascular remodeling via EGFR signaling in lung adenocarcinoma"**

- **作者**: Yamaguchi et al. (2010)

- **摘要**: 研究DCBLD2在肺癌中的功能,利用DCBLD2抗体通过免疫组化(IHC)和Western blot检测其在肿瘤组织的表达,发现其高表达与EGFR信号通路激活及患者预后不良相关。

2. **"Characterization of DCBLD2 as a novel pro-angiogenic factor in tumor microenvironment"**

- **作者**: Huang et al. (2016)

- **摘要**: 通过抗DCBLD2的阻断抗体和小鼠模型,证明DCBLD2通过促进血管内皮细胞迁移参与肿瘤血管生成,抗体抑制实验显著降低肿瘤生长速率。

3. **"DCBLD2 expression correlates with glioblastoma progression and immune infiltration"**

- **作者**: Saito et al. (2019)

- **摘要**: 使用DCBLD2抗体进行胶质母细胞瘤组织的免疫荧光染色,发现其高表达与肿瘤侵袭性和免疫抑制微环境相关,提示其作为治疗靶点的潜力。

4. **"Antibody-based detection of DCBLD2 in solid tumors: technical validation and clinical implications"**

- **作者**: Lee & Park (2021)

- **摘要**: 系统性验证多种商业DCBLD2抗体的特异性,优化IHC和流式细胞术检测流程,并探讨其在结直肠癌中的诊断价值。

建议通过 **PubMed/Google Scholar** 检索上述作者或关键词,获取全文及准确信息。

       

背景信息

The DCBLD2 (Discoidin, CUB and LCCL domain-containing protein 2) antibody is a tool used to detect and study the DCBLD2 protein, a transmembrane glycoprotein implicated in cell signaling and adhesion processes. DCBLD2. also known as CLCP1 or ESDN, contains structural domains (Discoidin, CUB, and LCCL) that suggest roles in protein-protein interactions and extracellular matrix regulation. It is expressed in various tissues, including vascular endothelium, neurons, and certain epithelial cells.

Research highlights DCBLD2's involvement in modulating receptor tyrosine kinase signaling, particularly EGFR, influencing cell proliferation, migration, and angiogenesis. Its dysregulation has been linked to cancer progression, with elevated expression observed in tumors like glioblastoma, lung cancer, and hepatocellular carcinoma, where it may promote invasiveness or serve as a prognostic marker.

The DCBLD2 antibody is essential for techniques such as Western blotting, immunohistochemistry (IHC), and immunofluorescence to quantify protein expression, assess localization, or explore mechanistic pathways in disease models. Recent studies also investigate its potential as a therapeutic target or biomarker. However, functional insights remain evolving, with ongoing research aimed at clarifying its precise biological roles and pathological contributions.

       
关键字: DCBLD2抗体;DCBLD2;DCBLD2 Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。
成立日期 2024-06-24 (2年) 注册资本 50万(元)
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 中间体,化学试剂 经营模式 贸易,工厂,试剂,定制,服务
  • 湖北瑞和宁生物科技有限公司
VIP 1年
  • 公司成立:2年
  • 注册资本:50万(元)
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:中间体。试剂
  • 公司地址:江汉区
询盘

店内推荐

DCBLD2抗体相关厂家报价

产品名称 价格   公司名称 报价日期
¥1950
VIP4年
上海沪震实业有限公司
2026-01-09
询价
VIP5年
上海冠导生物工程有限公司
2026-01-10
询价
VIP4年
维百奥(北京)生物科技有限公司
2025-12-29
¥1280
湖北艾普蒂生物工程有限公司
2025-06-04
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.